Acceleron Pharma Inc (XLRN.O) News|
United States

Acceleron Pharma Inc (XLRN.O)

XLRN.O on Consolidated Issue listed on NASDAQ Global Market

28 Jun 2016
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Fri, Jun 10 2016

BRIEF-Acceleron, Celgene says data with Luspatercept show increases in hemoglobin levels

* Acceleron and Celgene announce updated results from an ongoing Phase 2 study of Luspatercept in beta-thalassemia presented at the 21st congress of the European Hematology Association

BRIEF-Acceleron Pharma Q1 loss per share $0.13

* Acceleron Pharma reports first quarter 2016 financial and operational results

Select another date: